Cantor Fitzgerald reiterates a 'Buy' on Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) price target raised to $8.00.

Analyst, Mara Goldstein ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE